Interesting research results

high return and a good medical co.

This was the first stock I ever purchased. Since my purchase I am down 15%, but I believe it will stay steady at the price it is at currently and with any good news on the current trials could bring a nice jump

Need a cure for cancer bad!

Cancer drugs

ealy stage clinical biotech with 15 Phase2 clinical trials of 3 diffrent drugs: PanzemNCD (2ME2 nanocrytaldispersion); MKC-1, ENMD=-1198.
Drugs have multimechanisms of action and are being used for a multiplicity of cancers( glioblastoma multiforme, nslc-lung-, ovarian, kidney, multiple myeloma, prostate, advanced cancers, and Panzem is slated to be used also in inflammatory diseases, most notably rheumatoid arthritis.
Celgene owns 27.22% ofd voting stock, large ownership by insiders and institutions; cash on hand to go well into second half of 2008 with no debt. An ambitoius program with an administration which in the past 2 yers has met its deadliners on time; multiple other drugs in pipeline; impending partnership for its aurura kinase inhibitor with Big Pharma company .
Will be presenting 3 papers at ASCO June 1 through June 6, 2007
Currently unknown and underpriced

If any of the pipeline items hit phase 3 (multiple phase 2) this stock will blow up and returns will be amazing. I will be interested to hear what all is discussed at the BIO conference. This is a speculative stock, and everyone needs at least one.

Like the Cancer cure.

Oncology pipeline

Stock is Scraping a low.

overpromise, underdeliver

Bad mgmt

Lost capital